Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
alt text

For pharma companies looking to build digital health solutions or digital therapeutics (DTx), it’s essential to understand the different types of solutions available to them. What option is right for my product? What need will they address? What additional value does each option offer? How best to create and deliver them to market successfully?

In this webinar, industry experts share insights on the driving forces behind the different types of digital health solutions and DTx, and provide actionable advice on what to consider when developing these solutions:

    • What are the options and driving forces beyond the different types of Pharma sponsored digital health solutions and digital therapeutics (DTx)

    • What are the capabilities required to develop these solutions, and should I develop in-house?
    • End-to-end process for successful development and getting my partner strategy right

Speakers:

alt text

Jim O’Donoghue

President

S3 Connected Health

As President of S3 Connected Health, Jim leads a business which has delivered digital health solutions across 20 disease areas in 50 countries, in areas such as neurology, oncology, and immunology. Jim passionately believes that digital health will fundamentally change the way healthcare is delivered and experienced by patients and clinicians. A software engineer by background, Jim has over 20 years experience in Medical Device development ranging from Digital Therapeutics to connected, wearable, and implantable solutions. Jim is the current chairperson of the IBEC Digital Health Working Group and is involved in a number of industry bodies including the Digital Therapeutics Alliance.

alt text

Scott Snyder, PH.D.

Chief Digital Officer

Eversana

Dr. Snyder is a recognized thought leader in technology and innovation. He has more than 30 years of experience in emerging technologies, business strategy and innovation, and digital transformation for Global 1000 companies and startup ventures. He is the co-author of Goliath’s Revenge: How Established Companies Turn the Tables on Digital Disruptors and the author of The New World of Wireless: How to Compete in the 4G Revolution and numerous other articles on emerging technologies and innovation.

Dr. Snyder is currently the Chief Digital Officer of EVERSANA focused on accelerating the life sciences commercialization model. Dr. Snyder was recently the Global Head of Digital and Innovation at Heidrick Consulting. Before Heidrick, he was the Chief Technology and Innovation Officer at Safeguard Scientifics which provides capital and relevant expertise to fuel the growth of technology-driven businesses in healthcare, financial services and digital media. Prior to Safeguard, Dr. Snyder was the Co-Founder, President and Chief Strategy Officer at Mobiquity (recently acquired by Hexaware), a leader in delivering innovative mobile and digital solutions for enterprises. He has consulted on digital and business model innovation in the healthcare space for companies such as GSK, IQVIA, Novartis, J&J, Alcon, Medtronic, UPMC, Vitality, Weight Watchers, Guidewell, and Humana.

Dr. Snyder earned his B.S., M.S., and Ph.D. in Systems Engineering from University of Pennsylvania.

Hosted by

Maire Gerrard

Custom Content Writer

Informa Pharma Intelligence

Complete the form to watch this webinar on demand!

By ticking this box, you agree to receive emails such as relevant news, updates and offers from Informa Business Intelligence, and carefully selected similar products from our portfolio

By completing this form you agree S3 Connected Health and Pharma Intelligence may contact you directly about industry news, products, services and events that may be of interest. This is subject to S3 Connected Health’s privacy policy and Pharma Intelligence UK Ltd’s privacy policy.